Evidence map›Paper›PMID 34586557›Full record

ReviewChinese journal of integrative medicine2022

From Molecular Pathology of COVID 19 to Nigella Sativum as a Treatment Option: Scientific Based Evidence of Its Myth or Reality.

Muhammad Atif, Farrah Naz, Junaid Akhtar, Muhammad Imran, Sidrah Saleem, Javed Akram, Muhammad Imran, Muhammad Ikram Ullah

Open access · bronzeAbstract readReview
In one paragraph

Review in Chinese journal of integrative medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Muhammad AtifDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, 75471, Saudi Arabia.
Farrah NazDepartment of Microbiology, Government College University, Faisalabad, 38000, Pakistan.
Junaid AkhtarDepartment of Microbiology, University of Health Sciences, Lahore, 54600, Pakistan.
Muhammad ImranDepartment of Microbiology, University of Health Sciences, Lahore, 54600, Pakistan.
Sidrah SaleemDepartment of Microbiology, University of Health Sciences, Lahore, 54600, Pakistan.
Javed AkramUniversity of Health Sciences, Lahore, 54600, Pakistan.
Muhammad ImranUniversity Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore, 54590, Pakistan. mi.bannu@yahoo.com.
Muhammad Ikram UllahDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, 75471, Saudi Arabia.
Jouf University · SAUniversity of Health Sciences Lahore · PKUniversity of Lahore · PKGovernment College University, Faisalabad · PKUniversity of Sargodha · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 virus is a causative agent of viral pandemic in human beings which specifically targets respiratory system of humans and causes viral pneumonia. This unusual viral pneumonia is rapidly spreading to all parts of the world, currently affecting about 105 million people with 2.3 million deaths. Current review described history, genomic characteristics, replication, and pathogenesis of COVID-19 with special emphasis on Nigella sativum (N. sativum) as a treatment option. N. sativum seeds are historically and religiously used over the centuries, both for prevention and treatment of different diseases. This review summarizes the potential role of N. sativum seeds against COVID-19 infection at levels of in silico, cell lines and animal models.

Indexed as

COVID-19NigellaAnimalsHumansPandemicsPathology, MolecularSARS-CoV-2coronavirusCOVID-19nCoV-19Nigella sativumreview

Identifiers

PMID34586557
PMCPMC8479716
OpenAlexW3202843828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.